The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recom Mayne Pharma Group Limited (Mayne Pharma or the Company ...

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe ...

In a report released on March 6, Shane Storey from Wilsons maintained a Buy rating on Clarity Pharmaceuticals Ltd. (CU6 – Research Report), ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...

The Future Women Leaders Forum marks International Women’s Day with a powerful gathering Eugene Mayne, Founder and CEO of Tristar Group, delivering the welcome note at The Future Women Leaders ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.